‘LIVE’ POLIO VACCINE FIRES UP IMMUNE SYSTEM PROVIDING PROTECTION FROM SARS-CoV-2 INFECTION

Global Virus Network (GVN) studies suggest that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines Baltimore, Maryland, USA, March 31, 2022: Two new studies from the Global Virus Network (GVN) in partnership with the Petroleum Industry Health Organization of Iran provide evidence that getting…

Read More

Impact of Interferon on Disease Severity of Covid-19

Impact of Interferon on Disease Severity of Covid-19 March 28, 2022 Introduction  Types 1 and 3 interferon (IFN) expression and activity have been shown to play a significant role in determining the disease severity of SARS-CoV-2 infection. It is becoming clear that the timing of IFN expression is critical in the efficacy of the early…

Read More

Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis

Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis March 23, 2022 Introduction  Polio (poliomyelitis) is a highly infectious disease that mostly affects children under 5 years of age. The causative agent, poliovirus, replicates in the gut but in some cases can invade the central nervous system and cause permanent paralysis (approximately one in 200…

Read More

Global Virus Network Adds the Aegis Consortium as Newest Center of Excellence

Baltimore, Maryland, USA, March 23, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans and some animals, and the Aegis Consortium at the University of Arizona Health Sciences announced today the induction of Aegis as…

Read More

GVN Adds the Centre Scientifique de Monaco as Newest Member to Combat Viral Threats

Baltimore, Maryland, USA, March 22, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre Scientifique de Monaco (CSM) announced CSM as GVN’s newest Affiliate. “Just last year, we co-hosted a significant international…

Read More

Is Bradykinin Involved in Covid-19 Pathogenesis?

Is Bradykinin Involved in Covid-19 Pathogenesis? March 18, 2022 Inflammation  One of the hallmarks of Covid-19 disease is inflammation, mediated in part by overproduction of inflammatory cytokines. However, the mechanisms of such inflammatory process have not been clearly understood. In the past year the potential role of bradykinin, a small peptide and a members of…

Read More

Ongoing Outbreaks of Lassa Virus in Nigeria

Ongoing Outbreaks of Lassa Virus in Nigeria March 8, 2022 Context The first known confirmed Omicron (B.1.1.529) infection was from a specimen collected on November 9, 2021 in Botswana (1). The variant rapidly began to spread to South Africa and other Southern African countries. Nigeria also experienced daily surge of COVID-19 cases in December, and…

Read More

GVN Announces Inaugural Participants of Postdoctoral Fellowship Program

The three awardees will receive training and mentorship to help support and propel their rising careers in virology BALTIMORE, MD, March 8, 2022: The Global Virus Network (GVN), a coalition comprised of human and animal virologists from 68 Centers of Excellence and 10 Affiliates in 36 countries, today announced the three inaugural members of the GVN Postdoctoral…

Read More

A Statement from the Global Virus Network on the 2022 Russian Invasion of Ukraine

BALTIMORE, MD, March 2, 2022: The Global Virus Network (GVN) is an apolitical global organization comprised of the world’s leading scientists, including those from Russia and Ukraine, who specialize in education and research for the purpose of protecting mankind from viral proliferation and viruses that cause pandemics.  The scientists of the Global Virus Network collaborate to alleviate…

Read More